Over 10 years experience of Traceability Solutions
By pharmatrax
Category: Technoloy
No Comments A new model developed at MIT can help predict if patients at risk for Alzheimer’s disease will experience clinically significant cognitive decline due to the…
By pharmatrax
Category: Technoloy
No Comments There’s no human instinct more basic than speech, and yet, for many people, talking can be taxing. 1 in 14 working-age Americans suffer from voice…
By pharmatrax
Category: Technoloy
No Comments MIT computer scientists are hoping to accelerate the use of artificial intelligence to improve medical decision-making, by automating a key step that’s usually done by…
By pharmatrax
Category: Technoloy
No Comments Organizations looking to install blockchain networks should first consider sophisticated auditing, tracking and version control implementation, according to Auvesy CEO Robert Glaser and cited by Advanced…
By pharmatrax
Category: Technoloy
No Comments Tech giant IBM has launched a new blockchain network with several big-name companies such as Lenovo, Nokia, and Vodafone joining as founding participants, according to…
By pharmatrax
Category: Technoloy
No Comments Prescription medications are dangerous. Yes, they can cure certain infections or control chronic conditions, but there is a reason some pharmaceuticals cannot be bought over…
By pharmatrax
Category: Technoloy
No Comments Protecting patients from harm is not only part of the Hippocratic Oath, but one of the major goals and principals of modern medicine. However, this…
By pharmatrax
Category: Technoloy
No Comments NLP in healthcare According to recent research, application of natural language processing (NLP) and text analytics in the healthcare and life sciences industries is forecast…
By pharmatrax
Category: Technoloy
No Comments Pharmacovigilance (PV), the process of identifying, tracking, evaluating and preventing negative outcomes from drug therapies, is a sector that has seen huge growth in recent…
By pharmatrax
Category: Technoloy
No Comments Novo Nordisk must have liked what it saw in the first few months of its R&D tie-up with UK artificial intelligence company e-Therapeutics, as it…